Literature DB >> 22313528

CNS regulation of appetite.

Joanne A Harrold1, Terry M Dovey, John E Blundell, Jason C G Halford.   

Abstract

This article reviews the regulation of appetite from a biopsychological perspective. It considers psychological experiences and peripheral nutritional systems (both episodic and tonic) and addresses their relationship with the CNS networks that process and integrate their input. Whilst such regulatory aspects of obesity focus on homeostatic control mechanisms, in the modern environment hedonic aspects of appetite are also critical. Enhanced knowledge of the complexity of appetite regulation and the mechanisms that sustain obesity indicate the challenge presented by management of the obesity epidemic. Nonetheless, effective control of appetite expression remains a critical therapeutic target for weight management. Currently, strategies which utilise a combination of agents to target both homeostatic and hedonic control mechanisms represent the most promising approaches. This article is part of a Special Issue entitled 'Central Control of Food Intake'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22313528     DOI: 10.1016/j.neuropharm.2012.01.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  38 in total

1.  Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  Odors: appetizing or satiating? Development of appetite during odor exposure over time.

Authors:  M G Ramaekers; S Boesveldt; C M M Lakemond; M A J S van Boekel; P A Luning
Journal:  Int J Obes (Lond)       Date:  2013-08-06       Impact factor: 5.095

3.  On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

Review 4.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

5.  Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2013-03-01       Impact factor: 4.530

Review 6.  Reassessing wanting and liking in the study of mesolimbic influence on food intake.

Authors:  Saleem M Nicola
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-17       Impact factor: 3.619

Review 7.  Managing temptation in obesity treatment: A neurobehavioral model of intervention strategies.

Authors:  Bradley M Appelhans; Simone A French; Sherry L Pagoto; Nancy E Sherwood
Journal:  Appetite       Date:  2015-10-22       Impact factor: 3.868

8.  Contextual factors associated with eating in the absence of hunger among adults with obesity.

Authors:  Andrea B Goldschmidt; Ross D Crosby; Li Cao; Carolyn M Pearson; Linsey M Utzinger; Carly R Pacanowski; Tyler B Mason; Laura A Berner; Scott G Engel; Stephen A Wonderlich; Carol B Peterson
Journal:  Eat Behav       Date:  2017-01-17

Review 9.  Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.

Authors:  Laurence J Miller; Aditya J Desai
Journal:  Trends Endocrinol Metab       Date:  2016-05-04       Impact factor: 12.015

10.  Associations of ghrelin with eating behaviors, stress, metabolic factors, and telomere length among overweight and obese women: preliminary evidence of attenuated ghrelin effects in obesity?

Authors:  Julia Buss; Peter J Havel; Elissa Epel; Jue Lin; Elizabeth Blackburn; Jennifer Daubenmier
Journal:  Appetite       Date:  2014-01-22       Impact factor: 3.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.